We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Waters Corp. Boosts Progenesis QI Software with Proteolabels
Read MoreHide Full Article
Premium analytical laboratory instrument and software company, Waters Corporation (WAT - Free Report) , recently expanded its Progenesis QI software with the launch of Proteolabels. The company has agreed to offer Proteolabels through an exclusive agreement with Liverpool, U.K.-based start-up company Omic Analytics, that focuses on computational biology.
Proteolabels has been designed to support studies involving stable isotope labels. The company remains confident that this latest offering will extend the use of Progenesis QI for proteomics that will help address the needs of health sciences customers. Further, the software is also expected to find use in other fields, together with food and environmental research.
Proteolabels has been packed with a host of other features — including co-detection, to improve sensitivity; auto-detect, to simplify analysis; peptide scoring capability; and smart protein inference to boost protein-level quantitation. It is also armed with multiple QC metrics and data plotting options to gain deeper insights.
Waters Corp. has an active research and development (R&D) division focusing on the development and commercialization of products to gain a competitive edge over peers. Last week, the company showcased multiple offerings at the Pittcon Conference and Expo. It also launched a “cloud deployable, compliance ready enterprise Chromatography Data Software (CDS)” — Empower Cloud. Further, it expanded its TA Instruments product line by adding three 800 Series dilatometers as well as launching SDT 650.
Over the past three months, shares of Waters Corp. has appreciated 16.3%, outperforming the Zacks categorized Instruments-Scientific industry’s average return of 11.1%. The company has a decent earnings surprise history with an average positive surprise of 3.9%, beating estimates thrice over the trailing four quarters. Also, upward estimates revision over the past month raises our confidence in the stock.
In the last 30 days, the Zacks Consensus Estimate for 2017 earnings inched up from $7.01 to $7.02, reflecting bullish broker sentiment, as is evident from four upward versus no downward revision. We believe Waters Corp.’s strong position in the biopharma end markets, solid sales in the emerging markets, increased demand for research intensive products and favorable regulatory requirements will continue to act as major growth drivers for the Zacks Rank #3 (Hold) company.
Stocks to Consider
Some better-ranked stocks in the same space include Applied Materials, Inc. (AMAT - Free Report) , Science Applications International Corporation (SAIC - Free Report) and Ubiquiti Networks, Inc. . While Applied Materials sports a Zacks Rank #1 (Strong Buy), Science Applications and Ubiquiti Networks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
With four back-to-back earnings beat, Applied Materials has an average positive surprise of 3.9% for the last four quarters.
Science Applications International has a striking earnings surprise history for the trailing four quarters, having beaten estimates in each of them, for a remarkable average of 9.2%.
Ubiquiti Networks managed to beat earnings estimates thrice over the trailing four quarters. It has an average positive surprise of 14.3%.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Waters Corp. Boosts Progenesis QI Software with Proteolabels
Premium analytical laboratory instrument and software company, Waters Corporation (WAT - Free Report) , recently expanded its Progenesis QI software with the launch of Proteolabels. The company has agreed to offer Proteolabels through an exclusive agreement with Liverpool, U.K.-based start-up company Omic Analytics, that focuses on computational biology.
Proteolabels has been designed to support studies involving stable isotope labels. The company remains confident that this latest offering will extend the use of Progenesis QI for proteomics that will help address the needs of health sciences customers. Further, the software is also expected to find use in other fields, together with food and environmental research.
Proteolabels has been packed with a host of other features — including co-detection, to improve sensitivity; auto-detect, to simplify analysis; peptide scoring capability; and smart protein inference to boost protein-level quantitation. It is also armed with multiple QC metrics and data plotting options to gain deeper insights.
Waters Corp. has an active research and development (R&D) division focusing on the development and commercialization of products to gain a competitive edge over peers. Last week, the company showcased multiple offerings at the Pittcon Conference and Expo. It also launched a “cloud deployable, compliance ready enterprise Chromatography Data Software (CDS)” — Empower Cloud. Further, it expanded its TA Instruments product line by adding three 800 Series dilatometers as well as launching SDT 650.
Over the past three months, shares of Waters Corp. has appreciated 16.3%, outperforming the Zacks categorized Instruments-Scientific industry’s average return of 11.1%. The company has a decent earnings surprise history with an average positive surprise of 3.9%, beating estimates thrice over the trailing four quarters. Also, upward estimates revision over the past month raises our confidence in the stock.
In the last 30 days, the Zacks Consensus Estimate for 2017 earnings inched up from $7.01 to $7.02, reflecting bullish broker sentiment, as is evident from four upward versus no downward revision. We believe Waters Corp.’s strong position in the biopharma end markets, solid sales in the emerging markets, increased demand for research intensive products and favorable regulatory requirements will continue to act as major growth drivers for the Zacks Rank #3 (Hold) company.
Stocks to Consider
Some better-ranked stocks in the same space include Applied Materials, Inc. (AMAT - Free Report) , Science Applications International Corporation (SAIC - Free Report) and Ubiquiti Networks, Inc. . While Applied Materials sports a Zacks Rank #1 (Strong Buy), Science Applications and Ubiquiti Networks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
With four back-to-back earnings beat, Applied Materials has an average positive surprise of 3.9% for the last four quarters.
Science Applications International has a striking earnings surprise history for the trailing four quarters, having beaten estimates in each of them, for a remarkable average of 9.2%.
Ubiquiti Networks managed to beat earnings estimates thrice over the trailing four quarters. It has an average positive surprise of 14.3%.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>